Tear Corporation Logo

Tear Corporation

2485.T

(3.0)
Stock Price

431,00 JPY

3.68% ROA

9.15% ROE

13.79x PER

Market Cap.

10.082.110.528,00 JPY

149.51% DER

4.46% Yield

4.22% NPM

Tear Corporation Stock Analysis

Tear Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Tear Corporation Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (34%), which means it has a small amount of debt compared to the ownership it holds

2 Assets Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

3 Dividend

Investors can take comfort in the company's unwavering commitment to dividends, as it has consistently distributed payouts over the past five years, ensuring a reliable income stream.

4 ROE

ROE in an average range (7.28%) suggests satisfactory profitability and decent utilization of shareholders' equity.

5 ROA

The stock's ROA (3.83%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

6 PBV

The stock's PBV ratio (1.33x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

7 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

8 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

9 Buffet Intrinsic Value

The company's stock seems undervalued (12.543) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

10 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

11 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

Tear Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Tear Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Buy

Tear Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Tear Corporation Revenue
Year Revenue Growth
2008 5.867.609.000
2009 6.216.055.000 5.61%
2010 7.640.000.000 18.64%
2011 7.826.697.000 2.39%
2012 8.355.740.000 6.33%
2013 8.919.709.000 6.32%
2014 9.527.583.000 6.38%
2015 10.205.674.000 6.64%
2016 10.594.000.000 3.67%
2017 11.352.000.000 6.68%
2018 12.311.000.000 7.79%
2019 12.779.000.000 3.66%
2020 11.919.000.000 -7.22%
2021 12.203.000.000 2.33%
2022 13.283.000.000 8.13%
2023 14.068.000.000 5.58%
2024 19.080.000.000 26.27%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Tear Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2008 0
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Tear Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2008 201.471.000
2009 242.441.000 16.9%
2010 269.521.000 10.05%
2011 365.338.000 26.23%
2012 354.963.000 -2.92%
2013 394.946.000 10.12%
2014 411.197.000 3.95%
2015 424.211.000 3.07%
2016 469.000.000 9.55%
2017 2.349.000.000 80.03%
2018 2.623.000.000 10.45%
2019 2.915.000.000 10.02%
2020 3.061.000.000 4.77%
2021 2.900.000.000 -5.55%
2022 3.224.000.000 10.05%
2023 3.575.000.000 9.82%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Tear Corporation EBITDA
Year EBITDA Growth
2008 841.809.000
2009 909.145.000 7.41%
2010 1.305.079.000 30.34%
2011 1.366.306.000 4.48%
2012 1.505.865.000 9.27%
2013 1.650.727.000 8.78%
2014 1.757.980.000 6.1%
2015 1.833.448.000 4.12%
2016 2.054.000.000 10.74%
2017 1.750.000.000 -17.37%
2018 1.905.000.000 8.14%
2019 1.773.000.000 -7.45%
2020 1.220.000.000 -45.33%
2021 1.459.000.000 16.38%
2022 1.645.000.000 11.31%
2023 1.784.000.000 7.79%
2024 2.544.000.000 29.87%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Tear Corporation Gross Profit
Year Gross Profit Growth
2008 1.682.105.000
2009 1.860.126.000 9.57%
2010 2.411.876.000 22.88%
2011 2.527.875.000 4.59%
2012 2.786.713.000 9.29%
2013 3.103.419.000 10.21%
2014 3.365.554.000 7.79%
2015 3.687.994.000 8.74%
2016 3.916.000.000 5.82%
2017 4.293.000.000 8.78%
2018 4.840.000.000 11.3%
2019 5.061.000.000 4.37%
2020 4.556.000.000 -11.08%
2021 4.752.000.000 4.12%
2022 5.256.000.000 9.59%
2023 5.770.000.000 8.91%
2024 7.068.000.000 18.36%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Tear Corporation Net Profit
Year Net Profit Growth
2008 224.349.000
2009 276.654.000 18.91%
2010 404.722.000 31.64%
2011 354.129.000 -14.29%
2012 418.665.000 15.41%
2013 517.233.000 19.06%
2014 548.037.000 5.62%
2015 652.042.000 15.95%
2016 712.000.000 8.42%
2017 801.000.000 11.11%
2018 896.000.000 10.6%
2019 791.000.000 -13.27%
2020 345.000.000 -129.28%
2021 542.000.000 36.35%
2022 568.000.000 4.58%
2023 789.000.000 28.01%
2024 624.000.000 -26.44%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Tear Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2008 2.465
2009 3.039 18.86%
2010 44 -6804.55%
2011 39 -15.79%
2012 23 -72.73%
2013 28 21.43%
2014 30 6.67%
2015 33 6.25%
2016 35 8.57%
2017 40 10.26%
2018 44 11.36%
2019 36 -22.22%
2020 15 -140%
2021 24 37.5%
2022 25 4%
2023 35 28.57%
2024 28 -29.63%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Tear Corporation Free Cashflow
Year Free Cashflow Growth
2008 115.481.000
2009 -35.941.000 421.31%
2010 158.624.000 122.66%
2011 -303.487.000 152.27%
2012 74.624.000 506.69%
2013 299.081.000 75.05%
2014 594.355.000 49.68%
2015 261.881.000 -126.96%
2016 361.000.000 27.46%
2017 408.000.000 11.52%
2018 974.000.000 58.11%
2019 140.000.000 -595.71%
2020 223.000.000 37.22%
2021 743.000.000 69.99%
2022 445.000.000 -66.97%
2023 -82.000.000 642.68%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Tear Corporation Operating Cashflow
Year Operating Cashflow Growth
2008 411.725.000
2009 554.859.000 25.8%
2010 860.436.000 35.51%
2011 596.825.000 -44.17%
2012 924.228.000 35.42%
2013 805.582.000 -14.73%
2014 1.150.552.000 29.98%
2015 1.177.131.000 2.26%
2016 1.180.000.000 0.24%
2017 1.406.000.000 16.07%
2018 1.620.000.000 13.21%
2019 1.177.000.000 -37.64%
2020 986.000.000 -19.37%
2021 1.370.000.000 28.03%
2022 1.353.000.000 -1.26%
2023 1.272.000.000 -6.37%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Tear Corporation Capital Expenditure
Year Capital Expenditure Growth
2008 296.244.000
2009 590.800.000 49.86%
2010 701.812.000 15.82%
2011 900.312.000 22.05%
2012 849.604.000 -5.97%
2013 506.501.000 -67.74%
2014 556.197.000 8.93%
2015 915.250.000 39.23%
2016 819.000.000 -11.75%
2017 998.000.000 17.94%
2018 646.000.000 -54.49%
2019 1.037.000.000 37.7%
2020 763.000.000 -35.91%
2021 627.000.000 -21.69%
2022 908.000.000 30.95%
2023 1.354.000.000 32.94%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Tear Corporation Equity
Year Equity Growth
2008 1.231.301.000
2009 1.451.840.000 15.19%
2010 1.799.544.000 19.32%
2011 2.085.357.000 13.71%
2012 2.435.589.000 14.38%
2013 2.873.005.000 15.23%
2014 3.284.353.000 12.52%
2015 4.970.200.000 33.92%
2016 5.561.000.000 10.62%
2017 6.221.000.000 10.61%
2018 6.984.000.000 10.92%
2019 8.939.000.000 21.87%
2020 8.927.000.000 -0.13%
2021 9.022.000.000 1.05%
2022 7.500.000.000 -20.29%
2023 7.878.000.000 4.8%
2024 8.106.000.000 2.81%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Tear Corporation Assets
Year Assets Growth
2008 5.021.560.000
2009 6.058.488.000 17.12%
2010 6.716.311.000 9.79%
2011 7.298.916.000 7.98%
2012 8.079.048.000 9.66%
2013 8.504.401.000 5%
2014 8.913.282.000 4.59%
2015 10.137.064.000 12.07%
2016 10.069.000.000 -0.68%
2017 10.990.000.000 8.38%
2018 11.958.000.000 8.09%
2019 13.301.000.000 10.1%
2020 13.468.000.000 1.24%
2021 13.539.000.000 0.52%
2022 14.166.000.000 4.43%
2023 15.376.000.000 7.87%
2024 26.551.000.000 42.09%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Tear Corporation Liabilities
Year Liabilities Growth
2008 3.790.259.000
2009 4.606.648.000 17.72%
2010 4.916.767.000 6.31%
2011 5.213.559.000 5.69%
2012 5.643.459.000 7.62%
2013 5.631.396.000 -0.21%
2014 5.628.929.000 -0.04%
2015 5.166.864.000 -8.94%
2016 4.508.000.000 -14.62%
2017 4.769.000.000 5.47%
2018 4.974.000.000 4.12%
2019 4.362.000.000 -14.03%
2020 4.541.000.000 3.94%
2021 4.517.000.000 -0.53%
2022 6.666.000.000 32.24%
2023 7.498.000.000 11.1%
2024 18.442.000.000 59.34%

Tear Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
769.27
Net Income per Share
32.48
Price to Earning Ratio
13.79x
Price To Sales Ratio
0.58x
POCF Ratio
10.21
PFCF Ratio
10.2
Price to Book Ratio
1.24
EV to Sales
1.03
EV Over EBITDA
8.8
EV to Operating CashFlow
18.12
EV to FreeCashFlow
18.12
Earnings Yield
0.07
FreeCashFlow Yield
0.1
Market Cap
10,08 Bil.
Enterprise Value
17,90 Bil.
Graham Number
513.02
Graham NetNet
-596.47

Income Statement Metrics

Net Income per Share
32.48
Income Quality
1.3
ROE
0.09
Return On Assets
0.03
Return On Capital Employed
0.06
Net Income per EBT
0.61
EBT Per Ebit
0.92
Ebit per Revenue
0.07
Effective Tax Rate
0.38

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.4
Operating Profit Margin
0.07
Pretax Profit Margin
0.07
Net Profit Margin
0.04

Dividends

Dividend Yield
0.04
Dividend Yield %
4.46
Payout Ratio
0
Dividend Per Share
20

Operating Metrics

Operating Cashflow per Share
43.9
Free CashFlow per Share
43.9
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.04
Return on Tangible Assets
0.04
Days Sales Outstanding
17.27
Days Payables Outstanding
14.7
Days of Inventory on Hand
7.21
Receivables Turnover
21.14
Payables Turnover
24.84
Inventory Turnover
50.65
Capex per Share
0

Balance Sheet

Cash per Share
191,10
Book Value per Share
360,29
Tangible Book Value per Share
64.38
Shareholders Equity per Share
360.16
Interest Debt per Share
541.74
Debt to Equity
1.5
Debt to Assets
0.46
Net Debt to EBITDA
3.84
Current Ratio
0.99
Tangible Asset Value
1,45 Bil.
Net Current Asset Value
-12,79 Bil.
Invested Capital
18651000000
Working Capital
-0,03 Bil.
Intangibles to Total Assets
0.25
Average Receivables
0,81 Bil.
Average Payables
0,46 Bil.
Average Inventory
198000000
Debt to Market Cap
1.2

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Tear Corporation Dividends
Year Dividends Growth
2013 9
2014 6 -60%
2015 6 16.67%
2016 6 0%
2017 8 25%
2018 10 20%
2019 11 9.09%
2020 20 45%
2021 20 0%
2022 20 0%
2023 20 0%
2024 20 0%

Tear Corporation Profile

About Tear Corporation

Tear Corporation provides funeral services in Japan. The company operates funeral hall primarily in Chubu, Kansai, and Kanto districts. It also offers undertaking funerals and memorial services at the hall, as well as funeral and memorial services at temples, private homes, and public places; and follow-ups according to the consultation content of the bereaved families. Tear Corporation was incorporated in 1997 and is headquartered in Nagoya, Japan.

CEO
Mr. Norihisa Tomiyasu
Employee
646
Address
3-35-1, Kurokawahontori
Nagoya, 462-0841

Tear Corporation Executives & BODs

Tear Corporation Executives & BODs
# Name Age
1 Mr. Norihisa Tomiyasu
President, Chief Executive Officer & Representative Director
70
2 Mr. Tomoki Fujii
GM of Business Development Headquarters & Director
70
3 Mr. Katsumi Yamamoto
GM of Finance Division & Director
70
4 Mr. Shokichi Okadome
Executive Vice President of Funeral Business Headquarters, GM of Business Development Headquarters & Director
70
5 Mr. Kohei Tsuji
Senior MD, GM of Corporate Planning Headquarters and Management Headquarters & Director
70
6 Kenji Asahi
Manager of Human Resources Development Division
70
7 Mr. Kengo Manabe
Senior MD, GM of HR Capital Dev. Div., ESG Buss. Div. & Franchise Business Headquarters and Director
70

Tear Corporation Competitors